Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Stem Cell Transplantation in Progressive MS
NCT03269071Phase 1Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- May 2017
- Primary completion
- Jul 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of human fetal-derived neural stem cells in multiple sclerosis (MS) (4 cohorts), sponsored by IRCCS Ospedale San Raffaele. Primary endpoints: Overall survival, Overall safety and tolerability measured by Adverse Event (AE) recording and 4 more. Started May 2017; status: completed.
02
Drugs
human fetal-derived neural stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03269071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269071.